“…Five hundred and ten of 595 genes (85.7%) that significantly increase during both processes increase more following BLM, whereas 200 of 267 (74.9%) common decreased genes decrease more following BLM. Furthermore, we identified several genes previously documented to moderate pro‐fibrotic responses uniquely upregulated after PNX but not BLM (Figure 3f), including Ptgs2 , responsible for synthesis of the antifibrotic prostaglandin E2 (Bauman et al., 2010; Huang et al., 2007; Keerthisingam et al., 2001; Lama et al., 2002), Bone Morphogenetic Protein (BMP) ligands ( Bmp2 , Bmp7 ) (De Langhe et al., 2015; Guan et al., 2022; Pegorier et al., 2010; Tan et al., 2019), the Nuclear Receptor 4A (NR4A) Family ( Nr4a1 , Nr4a2 , Nr4a3 ), and the aldehyde dehydrogenase (ALDH) gene superfamily ( Aldh1a1 ) (Ma et al., 2018; Takahashi et al., 2021; Wang et al., 2023). These previously described anti‐fibrotic transcripts elevated after PNX but not BLM might contribute to the lower magnitude of fibrotic responses in PNX compared with BLM (Figure 3e).…”